Metabolic-Fit / 100
Eve review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
A current public medication-and-care total for Eve is not established. Earlier $195 injection and sublingual quotes and the $99 introductory offer are historical, rather than confirmed current prices. Ask for the exact drug, formulation, billing period, supply duration and renewal charge before paying.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Eve at a glance
- Semaglutide
- $195/mo flat — historical; current quote unconfirmed
- Tirzepatide
- $195/mo flat — historical; current quote unconfirmed
- Coverage
- Multiple states (not fully enumerated — confirm yours before signing up)
- Brand-name
- Yes
How we scored Eve
Every factor comes from Eve's own published pricing, disclosures and oversight, and the six combine into the 49/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Cancellation is workable but not frictionless.
How we checked this review
A current public medication-and-care total for Eve is not established. Earlier $195 injection and sublingual quotes and the $99 introductory offer are historical, rather than confirmed current prices. Ask for the exact drug, formulation, billing period, supply duration and renewal charge before paying.
Before you sign up
What Eve's public site and signup page show before you hand over any details.
Worth knowing
- The intake runs on Bask Health rather than on the provider's own software
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $195 | Injection, either moleculeHistorical listed price; current public pages did not reconfirm this offer or its billing terms. |
| Compounded tirzepatide | $195 | Injection, either moleculeHistorical listed price; current public pages did not reconfirm this offer or its billing terms. |
| Oral semaglutide | $195 | SublingualHistorical listed price; current public pages did not reconfirm this offer or its billing terms. |
| Brand semaglutide | $1399 | Ozempic®Historical listed price; current public pages did not reconfirm this offer or its billing terms. |
| Brand semaglutide | $1699 | Wegovy®Historical listed price; current public pages did not reconfirm this offer or its billing terms. |
| Brand tirzepatide | $1399 | Mounjaro®Historical listed price; current public pages did not reconfirm this offer or its billing terms. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Eve's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Also offers brand-name Ozempic, Wegovy, and Mounjaro for mothers who want an FDA-approved pen
The caveats
- Current medication-and-care pricing requires a written quote.
- No published state list — coverage is confirmed only after you start intake or relocate
- Full per-dose pricing is gated behind the signup application, not visible on the public marketing page
- Named pharmacy, 503A/503B designation, and medical director are not disclosed anywhere public
A current complete price is not publicly established
Eve’s public presentation describes clinician-led treatment without a dependable current medication-and-care total. Earlier records list $195 monthly for compounded injection or sublingual options, but that is a historical quote rather than a confirmed offer available now. A reader should request current terms before using the old amount to compare services.
The same caution applies to an earlier first-order code associated with a $99 introduction. A code fragment on a marketing page does not establish its present eligibility, what prescription it covers or the charge that follows. Ask for the first payment, renewal payment and period supplied together, including every mandatory care, medication and delivery component.
The gated catalog changes what can be assessed in advance
Eve’s fuller pricing catalog sits behind its signup application rather than on the public marketing page. That makes it harder to evaluate dose, formulation and ongoing cost before deciding whether to proceed. A public quote request is useful if it can answer those questions without making the patient rely on an older headline or incomplete promotional fragment.
An earlier program description used one flat amount across different compounded formulations. Do not assume that structure survives unchanged or that the same price now applies to both molecules. The selected drug, route, quantity and dose need their own current explanation, particularly if a reader is interested in a sublingual product rather than an injection.
A brand menu needs its own pharmacy total
Eve has also described brand options including Ozempic, Wegovy and Mounjaro. Older cash amounts for those products should not be carried forward as today’s price or assumed to include every care charge. Ask which brand route is currently available and how medication and clinical services are billed for the actual prescription.
Brand access and a compounded offering answer different product preferences. A familiar ingredient name does not make a compounded formulation identical to a named approved medicine. The clinician should explain the proposed product, while the pharmacy should identify the actual medication supplied, its quantity, storage and instructions. Neither a broad menu nor a historical flat price settles those details.
Certification presentation does not identify the treating team
Eve displays a LegitScript identifier in its public footer. That provides a certification claim to check against the current registry, rather than proof that every related service or prescription has been independently assessed. The available public material does not name a dispensing pharmacy or medical director, leaving important professional identities to establish directly.
Its earlier intake entry used a Bask Health platform. A software vendor’s involvement does not make that vendor the treating practice or establish ownership of the consumer brand. Ask which medical organization holds the patient relationship, who reviews the assessment and how ongoing clinical questions reach the responsible professional rather than general administrative support.
Confirm access before relying on continuity language
Eve does not publish a complete state list. Its continuity language refers to relocating to a state it serves, which makes state-specific confirmation important rather than establishing access everywhere. Confirm the intended location and treatment route before assuming that a prescription or care relationship can continue after a move.
Eve may interest someone willing to obtain a current individualized quote before comparing its range of options. Its principal limitation is the lack of a dependable public total, compounded by missing pharmacy and state details. The decision should rest on the actual agreement, responsible clinical team and refill terms, with the old $195 amount and introductory code kept clearly historical rather than treated as promises about the present service.
The bottom line for mothers
Best for: Mothers who want a single, predictable price no matter which molecule they end up on, and who don't mind confirming state coverage directly before paying.
Alternatives to Eve
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Eden47
Metabolic-Fit / 100
FDA warning letter #728279 (June 2026), which names Eden's website — read that first. Then read the price twice: the advertised $99 is medication alone, with a required $99-a-month membership on top.
- Visit Wellorithm42
Metabolic-Fit / 100
Compounded GLP-1s as an injection or an oral dissolving tablet, plus brand pens from $899 a month on a 3-month plan, in 49 states — but compounded prices appear only after the assessment and no cancellation policy is published.
Providers like Eve
Keep comparing Eve
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Related reading for mothers
Eve, answered
- Does Eve currently charge the same amount for both medicines?
- A current public medication-and-care total is not established. Earlier $195 monthly injection and sublingual prices and a $99 introductory code are historical, not a confirmed current offer. Obtain a written drug-specific total, billing period and renewal charge.
- Which states does Eve serve?
- Eve doesn't publish a state list. Its own copy only says the plan will 'follow you if you relocate to a state we currently serve' — reassuring for continuity, but it means you can't check coverage before you start intake. Confirm your state directly before paying.
- Is Eve's pricing actually public?
- Current public pricing was not available on the pages reviewed. Earlier prices should be confirmed directly before choosing a plan.
Pricing, states and verification reflect Eve's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.